(Q37963294)

26 August 2017

title

Muscle CARs and TcRs: turbo-charged technologies for the (T cell) masses (English)

1 reference

26 August 2017

Michael Kalos

1

1 reference

26 August 2017

publication date

1 December 2011

1 reference

Cancer Immunology, Immunotherapy

26 August 2017

published in

1 reference

26 August 2017

volume

61

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

127-135

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-011-1173-5

26 August 2017

exact match

0 references

cites work

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

A listing of human tumor antigens recognized by T cells: March 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Cancer/testis (CT) antigens: potential targets for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Melanoma-associated antigen genes - an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue-specific vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Human TCR-binding affinity is governed by MHC class restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Adoptive cell therapy: genetic modification to redirect effector cell specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Engineering higher affinity T cell receptors using a T cell display system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Directed evolution of human T-cell receptors with picomolar affinities by phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Subtle affinity-enhancing mutations in a myelin oligodendrocyte glycoprotein-specific TCR alter specificity and generate new self-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

The promise and potential pitfalls of chimeric antigen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Autoimmunity associated with immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

A fast and robust method to clone and functionally validate T-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Reconstitution of paired T cell receptor alpha- and beta-chains from microdissected single cells of human inflammatory tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Facilitating matched pairing and expression of TCR chains introduced into human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

PiggyBac transposon-mediated gene transfer in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

A transposon and transposase system for human application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

An inducible caspase 9 safety switch for T-cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

The T cell receptor: the α and β chains define idiotype, and antigen and MHC specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1173-5

10.1007/S00262-011-1173-5

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference